Full Text View
Tabular View
No Study Results Posted
Related Studies
Harvard Atherosclerosis Reversibility Project (HARP)
This study has been completed.
Study NCT00000461   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Additional conditions recognized in this trial
Coronary Artery Disease
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
pravastatin
niacin
cholestyramine
gemfibrozil
fatty acids, omega-3
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services